Connect
MJA
MJA

Darker side of “wonder drugs”

Med J Aust 2005; 182 (6): .
Published online: 28 April 2004

Together with Ralph Nader, Medawar began his career as a consumer advocate in the United States some 30 years ago, and experience has taught him the need for persistence and assertiveness in challenging the prevailing view in psychiatry. Recent scientific publications have largely vindicated his claims that the newer antidepressant drugs cause dependence and suicidal behaviour, and have poor efficacy; that the pharmaceutical industry is in the business of disease promotion; and that much “expert opinion” is compromised.



Correspondence: 

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.